Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2019 | 10-2018 | 10-2017 | 10-2016 | 10-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 0 | 42 | 46 | 49 |
| Accounts receivable | 112 | -49 | 29 | -36 | 22 |
| Accounts payable and accrued liabilities | -43 | 42 | N/A | N/A | N/A |
| Other Working Capital | 43 | 32 | 218 | -68 | 74 |
| Other Operating Activity | -171 | 9 | -298 | -107 | -598 |
| Operating Cash Flow | $-59 | $34 | $-9 | $-165 | $-453 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 0 | -34 |
| Net Acquisitions | 0 | -65 | N/A | N/A | N/A |
| Investing Cash Flow | $0 | $-65 | $N/A | $0 | $-34 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 20 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 0 | 300 |
| Financing Cash Flow | $20 | $N/A | $N/A | $0 | $300 |
| Exchange Rate Effect | N/A | 0 | -1 | 7 | 94 |
| Beginning Cash Position | 70 | 101 | 112 | 270 | 362 |
| End Cash Position | 31 | 70 | 101 | 112 | 270 |
| Net Cash Flow | $-39 | $-31 | $-9 | $-165 | $-186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59 | 34 | -9 | -165 | -453 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -34 |
| Free Cash Flow | -59 | 34 | -9 | -165 | -486 |